BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 26387962)

  • 21. Trends in centralization of surgical care and compliance with National Cancer Center Network guidelines for resected cholangiocarcinoma.
    Idrees JJ; Merath K; Gani F; Bagante F; Mehta R; Beal E; Cloyd JM; Pawlik TM
    HPB (Oxford); 2019 Aug; 21(8):981-989. PubMed ID: 30591307
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Failure to comply with NCCN guidelines for the management of pancreatic cancer compromises outcomes.
    Visser BC; Ma Y; Zak Y; Poultsides GA; Norton JA; Rhoads KF
    HPB (Oxford); 2012 Aug; 14(8):539-47. PubMed ID: 22762402
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disparities in Adherence to National Comprehensive Cancer Network Treatment Guidelines and Survival for Stage IB-IIA Cervical Cancer in California.
    Pfaendler KS; Chang J; Ziogas A; Bristow RE; Penner KR
    Obstet Gynecol; 2018 May; 131(5):899-908. PubMed ID: 29630020
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reasons for failure to deliver National Comprehensive Cancer Network (NCCN)-adherent care in the treatment of epithelial ovarian cancer at an NCCN cancer center.
    Erickson BK; Martin JY; Shah MM; Straughn JM; Leath CA
    Gynecol Oncol; 2014 May; 133(2):142-6. PubMed ID: 24517876
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adherence to European ovarian cancer guidelines and impact on survival: a French multicenter study (FRANCOGYN).
    Jochum F; De Rozario T; Lecointre L; Faller E; Boisrame T; Dabi Y; Lavoué V; Coutant C; Touboul C; Bolze PA; Bricou A; Canlorbe G; Collinet P; Huchon C; Bendifallah S; Ouldamer L; Mezzadri M; Querleu D; Akladios C
    Int J Gynecol Cancer; 2021 Nov; 31(11):1443-1452. PubMed ID: 34607855
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Impact of Hospital Quality on Thyroid Cancer Survival.
    Megwalu UC; Ma Y; Hernandez-Boussard T; Divi V; Gomez SL
    Otolaryngol Head Neck Surg; 2020 Mar; 162(3):269-276. PubMed ID: 31961755
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of Hospital Volume and Quality of Care With Survival for Ovarian Cancer.
    Wright JD; Chen L; Hou JY; Burke WM; Tergas AI; Ananth CV; Neugut AI; Hershman DL
    Obstet Gynecol; 2017 Sep; 130(3):545-553. PubMed ID: 28796677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer Center Volume and Type Impact Stage-Specific Utilization of Neoadjuvant Therapy in Rectal Cancer.
    Midura EF; Jung AD; Daly MC; Hanseman DJ; Davis BR; Shah SA; Paquette IM
    Dig Dis Sci; 2017 Aug; 62(8):1906-1912. PubMed ID: 28501970
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Population-Based Analysis of Patient Age and Other Disparities in the Treatment of Ovarian Cancer in Central Appalachia and Kentucky.
    Ore RM; Chen Q; DeSimone CP; Miller RW; Baldwin LA; van Nagell JR; Huang B; Tucker TC; Johnson MS; Fredericks TI; Ueland FR
    South Med J; 2018 Jun; 111(6):333-341. PubMed ID: 29863220
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The National Cancer Database report on advanced-stage epithelial ovarian cancer: impact of hospital surgical case volume on overall survival and surgical treatment paradigm.
    Bristow RE; Palis BE; Chi DS; Cliby WA
    Gynecol Oncol; 2010 Sep; 118(3):262-7. PubMed ID: 20573392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specialized care and survival of ovarian cancer patients in The Netherlands: nationwide cohort study.
    Vernooij F; Heintz AP; Witteveen PO; van der Heiden-van der Loo M; Coebergh JW; van der Graaf Y
    J Natl Cancer Inst; 2008 Mar; 100(6):399-406. PubMed ID: 18334710
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of the relationship between hospital characteristics and survival in ovarian cancer: A historical cohort.
    Moterani VC; Tiezzi DG; de Andrade JM; Candido Dos Reis FJ
    J Surg Oncol; 2020 Dec; 122(8):1802-1807. PubMed ID: 32851684
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surgical outcomes and national comprehensive cancer network compliance in advanced ovarian cancer surgery in a low volume military treatment facility.
    Phippen NT; Barnett JC; Lowery WJ; Miller CR; Leath CA
    Gynecol Oncol; 2013 Oct; 131(1):158-62. PubMed ID: 23872110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ninety-Day Mortality as a Reporting Parameter for High-Grade Serous Ovarian Cancer Cytoreduction Surgery.
    Spencer RJ; Hacker KE; Griggs JJ; Rice LW; Reynolds RK; Uppal S
    Obstet Gynecol; 2017 Aug; 130(2):305-314. PubMed ID: 28697111
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of guideline adherence on patient outcomes in early-stage epithelial ovarian cancer.
    Lee JY; Kim TH; Suh DH; Kim JW; Kim HS; Chung HH; Park NH; Song YS; Kang SB
    Eur J Surg Oncol; 2015 Apr; 41(4):585-91. PubMed ID: 25624160
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is It Time to Centralize Ovarian Cancer Care in the United States?
    Cowan RA; O'Cearbhaill RE; Gardner GJ; Levine DA; Roche KL; Sonoda Y; Zivanovic O; Tew WP; Sala E; Lakhman Y; Vargas Alvarez HA; Sarasohn DM; Mironov S; Abu-Rustum NR; Chi DS
    Ann Surg Oncol; 2016 Mar; 23(3):989-93. PubMed ID: 26511267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ovarian cancer in the United States: contemporary patterns of care associated with improved survival.
    Cliby WA; Powell MA; Al-Hammadi N; Chen L; Philip Miller J; Roland PY; Mutch DG; Bristow RE
    Gynecol Oncol; 2015 Jan; 136(1):11-7. PubMed ID: 25449311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adherence to guidelines at the patient- and hospital-levels is associated with improved overall survival in patients with gastric cancer.
    Kaslow SR; Ma Z; Hani L; Prendergast K; Vitiello G; Lee AY; Berman RS; Goldberg JD; Correa-Gallego C
    J Surg Oncol; 2022 Sep; 126(3):479-489. PubMed ID: 35471731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of treatment center and hospital volume on survival for locally advanced cervical cancer.
    Wright JD; Huang Y; Ananth CV; Tergas AI; Duffy C; Deutsch I; Burke WM; Hou JY; Neugut AI; Hershman DL
    Gynecol Oncol; 2015 Dec; 139(3):506-12. PubMed ID: 26177552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disparities in ovarian cancer treatment and overall survival according to race: An update.
    Huffman DL; Jayakrishnan TT; Shankar K; Peterson CE; Wegner RE
    Gynecol Oncol; 2021 Sep; 162(3):674-678. PubMed ID: 34261593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.